Authors:
Ongini, E
Monopoli, A
Impagnatiello, F
Fredduzzi, S
Schwarzschild, M
Chen, JF
Citation: E. Ongini et al., Dual actions of A(2A) adenosine receptor antagonists on motor dysfunction and neurodegenerative processes, DRUG DEV R, 52(1-2), 2001, pp. 379-386
Authors:
Izzo, E
Auta, J
Impagnatiello, F
Pesold, C
Guidotti, A
Costa, E
Citation: E. Izzo et al., Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines, P NAS US, 98(6), 2001, pp. 3483-3488
Authors:
Chen, JF
Moratalla, R
Impagnatiello, F
Grandy, DK
Cuellar, B
Rubinstein, M
Beilstein, MA
Hackett, E
Fink, JS
Low, MJ
Ongini, E
Schwarzschild, MA
Citation: Jf. Chen et al., The role of the D2 dopamine receptor (D2R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D-2 receptor knockout mice, P NAS US, 98(4), 2001, pp. 1970-1975
Authors:
Pagano, SF
Impagnatiello, F
Girelli, M
Cova, L
Grioni, E
Onofri, M
Cavallaro, M
Etteri, S
Vitello, F
Giombini, S
Solero, CL
Parati, EA
Citation: Sf. Pagano et al., Isolation and characterization of neural stem cells from the adult human olfactory bulb, STEM CELLS, 18(4), 2000, pp. 295-300
Authors:
Guidotti, A
Auta, J
Davis, JM
Gerevini, VD
Dwivedi, Y
Grayson, DR
Impagnatiello, F
Pandey, G
Pesold, C
Sharma, R
Uzunov, D
Costa, E
Citation: A. Guidotti et al., Decrease in reelin and glutamic acid decarboxylase(67) (GAD(67)) expression in schizophrenia and bipolar disorder - A postmortem brain study, ARCH G PSYC, 57(11), 2000, pp. 1061-1069
Authors:
Uz, T
Dwivedi, Y
Savani, PD
Impagnatiello, F
Pandey, G
Manev, H
Citation: T. Uz et al., Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain, J NEUROCHEM, 73(2), 1999, pp. 693-699
Authors:
Impagnatiello, F
Guidotti, AR
Pesold, C
Dwivedi, Y
Caruncho, H
Pisu, MG
Uzunov, DP
Smalheiser, NR
Davis, JM
Pandey, GN
Pappas, GD
Tueting, P
Sharma, RP
Costa, E
Citation: F. Impagnatiello et al., A decrease of reelin expression as a putative vulnerability factor in schizophrenia, P NAS US, 95(26), 1998, pp. 15718-15723